Biblio

Export 417 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Keyword is S  [Clear All Filters]
2016
W. - X. Li, Dai, S. - X., Liu, J. - Q., Wang, Q., Li, G. - H., and Huang, J. - F., Integrated Analysis of Alzheimer's Disease and Schizophrenia Dataset Revealed Different Expression Pattern in Learning and Memory., J Alzheimers Dis, vol. 51, no. 2, pp. 417-25, 2016.
Y. Yoo, Shin, S. A., Park, S., Lee, J. - H., Youn, J. - H., Kim, Y. Kyeong, and Lee, J. - Y., The Korean Size/Weight Attribute Test: A Semantic Knowledge Test for Korean Older Adults and Brain-Imaging Evidence., J Alzheimers Dis, vol. 49, no. 2, pp. 377-86, 2016.
S. Agostini, Mancuso, R., Baglio, F., Cabinio, M., Hernis, A., Guerini, F. Rosa, Calabrese, E., Nemni, R., and Clerici, M., Lack of evidence for a role of HHV-6 in the pathogenesis of Alzheimer's disease., J Alzheimers Dis, vol. 49, no. 1, pp. 229-35, 2016.
B. Downer, Veeranki, S. P., and Wong, R., A Late Life Risk Index for Severe Cognitive Impairment in Mexico., J Alzheimers Dis, vol. 52, no. 1, pp. 191-203, 2016.
B. Downer, Veeranki, S. P., and Wong, R., A Late Life Risk Index for Severe Cognitive Impairment in Mexico., J Alzheimers Dis, vol. 52, no. 1, pp. 191-203, 2016.
C. E. Fischer, Qian, W., Schweizer, T. A., Millikin, C. P., Ismail, Z., Smith, E. E., Lix, L. M., Shelton, P., and Munoz, D. G., Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 1, pp. 283-95, 2016.
C. E. Fischer, Qian, W., Schweizer, T. A., Millikin, C. P., Ismail, Z., Smith, E. E., Lix, L. M., Shelton, P., and Munoz, D. G., Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 1, pp. 283-95, 2016.
K. C. Fraser, Meltzer, J. A., and Rudzicz, F., Linguistic Features Identify Alzheimer's Disease in Narrative Speech., J Alzheimers Dis, vol. 49, no. 2, pp. 407-22, 2016.
F. Huang, Shang, Y., Luo, Y., Wu, P., Huang, X., Tan, X., Lu, X., Zhen, L., and Hu, X., Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors., J Alzheimers Dis, vol. 50, no. 3, pp. 659-67, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium., J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
R. Langlois, Joubert, S., Benoit, S., Dostie, V., and Rouleau, I., Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease: The Importance of Rehearsal., J Alzheimers Dis, vol. 50, no. 4, pp. 1023-33, 2016.
S. Min Son, Shin, H. - J., Byun, J., Kook, S. Young, Moon, M., Chang, Y. Jin, and Mook-Jung, I., Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation., J Alzheimers Dis, vol. 51, no. 4, pp. 1197-208, 2016.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E., Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial., J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
D. S Han, Boyle, P. A., James, B. D., Yu, L., and Bennett, D. A., Mild Cognitive Impairment and Susceptibility to Scams in Old Age., J Alzheimers Dis, vol. 49, no. 3, pp. 845-51, 2016.
M. Edwards, Hall, J., Williams, B., Johnson, L., and O'Bryant, S., Molecular markers of amnestic mild cognitive impairment among Mexican Americans., J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
M. Chakrabarti, McDonald, A. J., J Reed, W., Moss, M. A., Das, B. C., and Ray, S. K., Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 335-52, 2016.
S. V. Ovsepian and O'Leary, V. B., Neuronal activity and amyloid plaque pathology: an update., J Alzheimers Dis, vol. 49, no. 1, pp. 13-9, 2016.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M., Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology., J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
M. Fà, Zhang, H., Staniszewski, A., Saeed, F., Shen, L. W., Schiefer, I. T., Siklos, M. I., Tapadar, S., Litosh, V. A., Libien, J., Petukhov, P. A., Teich, A. F., Thatcher, G. R. J., and Arancio, O., Novel Selective Calpain 1 Inhibitors as Potential Therapeutics in Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 707-21, 2016.
C. Sanders, Behrens, S., Schwartz, S., Wengreen, H., Corcoran, C. D., Lyketsos, C. G., and Tschanz, J. A. T., Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1., J Alzheimers Dis, vol. 52, no. 1, pp. 33-42, 2016.
C. Sanders, Behrens, S., Schwartz, S., Wengreen, H., Corcoran, C. D., Lyketsos, C. G., and Tschanz, J. A. T., Nutritional Status is Associated with Faster Cognitive Decline and Worse Functional Impairment in the Progression of Dementia: The Cache County Dementia Progression Study1., J Alzheimers Dis, vol. 52, no. 1, pp. 33-42, 2016.
G. Tumminelli, Di Donato, I., Guida, V., Rufa, A., De Luca, A., and Federico, A., Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene., J Alzheimers Dis, vol. 49, no. 1, pp. 27-30, 2016.
P. Banerjee, Sahoo, A., Anand, S., Bir, A., and Chakrabarti, S., The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
A. Malara, De Biase, G. Andrea, Bettarini, F., Ceravolo, F., Di Cello, S., Garo, M., Praino, F., Settembrini, V., Sgrò, G., Spadea, F., and Rispoli, V., Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia., J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.
A. Malara, De Biase, G. Andrea, Bettarini, F., Ceravolo, F., Di Cello, S., Garo, M., Praino, F., Settembrini, V., Sgrò, G., Spadea, F., and Rispoli, V., Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia., J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.

Pages